UBS Group’s CORMEDIX INC WTS EXP 04/30/15 CRMD.WS Stock Holding History

UBS Group’s Portfolio CRMD.WS Stock Details CRMD.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,304	Closed	-$21K	–	9281
2015 Q1	$21K	Sell	3,304 -24	-0.7%	-$50	﹤0.01%	6969
2014 Q4	$0	Buy	+3,328	New	+$697	﹤0.01%	9722

UBS Group's CRMD.WS Position: Q2 2015 in Review

UBS Group sold out of CORMEDIX INC WTS EXP 04/30/15 (CRMD.WS) in Q2 2015, closing a stake of 3,304 shares — an estimated $21K sold.

UBS Group first reported a position in CRMD.WS in Q4 2014 and held it in 2 quarters. The position peaked at $21K in Q1 2015. 0 funds tracked by Wall St. Rank hold CRMD.WS as of Q2 2015.

UBS Group reported no remaining CORMEDIX INC WTS EXP 04/30/15 position as of Q2 2015 after selling out during the quarter.
UBS Group sold 3,304 CORMEDIX INC WTS EXP 04/30/15 shares in Q2 2015, an estimated $21K.
UBS Group first reported a position in CORMEDIX INC WTS EXP 04/30/15 in Q4 2014 and held it in 2 quarters.
UBS Group's CORMEDIX INC WTS EXP 04/30/15 position peaked at $21K in Q1 2015.
0 funds tracked by Wall St. Rank held CORMEDIX INC WTS EXP 04/30/15 as of Q2 2015.

Based on UBS Group's 13F filing for Q2 2015, filed 14 Aug 2015.